Hanyang Med Rev.  2017 May;37(1):34-39. 10.7599/hmr.2017.37.1.34.

Overview of symptoms, pathogenesis, diagnosis, treatment, and prognosis of various acquired polyneuropathies

Affiliations
  • 1Department of Neurology, Bundang Jesaeng Hospital, Gyeonggi, South Korea.
  • 2Department of Neurology, Hanyang University Guri Hospital, Gyeonggi, South Korea. ksh213@hanyang.ac.kr

Abstract

Polyneuropathy includes a lot of diseases damaging peripheral nerves. It shows roughly the same areas on both sides of the body, featuring weakness, numbness, and burning pain. Polyneuropathy is known to usually begin in the hands and feet and progress to the arms and legs. Sometimes it can involve other parts of the body such as the autonomic nervous system. Lots of causes can induce acute or chronic polyneuropathy, so finding the original cause is most important for the treatment of polyneuropathy. There are too many different types of polyneuropathies to be discussed in this review, so we will discuss some of various acquired polyneuropathies such as diabetic neuropathy, vasculitic neuropathy, alcoholic neuropathy, Vitamin B12 deficiency neuropathy, and drug-induced neuropathy, with special focus on symptoms, pathogenesis, diagnosis, treatment, and prognosis.

Keyword

Polyneuropathies; Symptoms; Diagnosis; Pathophysiology; Treatment

MeSH Terms

Alcoholic Neuropathy
Arm
Autonomic Nervous System
Burns
Diabetic Neuropathies
Diagnosis*
Foot
Hand
Hypesthesia
Leg
Peripheral Nerves
Polyneuropathies*
Prognosis*
Vitamin B 12 Deficiency

Cited by  1 articles

Current update in diverse diseases
Seong-Ho Koh
Hanyang Med Rev. 2017;37(1):1-1.    doi: 10.7599/hmr.2017.37.1.1.


Reference

1. Hughes RA. Peripheral neuropathy. BMJ. 2002; 324:466–469.
2. Barohn RJ, Amato AA. Pattern-recognition approach to neuropathy and neuronopathy. Neurol Clin. 2013; 31:343–361.
Article
3. Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015; 6:15–28.
Article
4. Kanji JN, Anglin RE, Hunt DL, Panju A. Does this patient with diabetes have large-fiber peripheral neuropathy? JAMA. 2010; 303:1526–1532.
Article
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med. 1995; 122:561–568.
6. Griebeler ML, Morey-Vargas OL, Brito JP, Tsapas A, Wang Z, Carranza Leon BG, et al. Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis. Ann Intern Med. 2014; 161:639–649.
Article
7. Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011; 76:1758–1765.
Article
8. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004; 63:865–873.
Article
9. Wiktorsson-Moller M, Oberg B, Ekstrand J, Gillquist J. Effects of warming up, massage, and stretching on range of motion and muscle strength in the lower extremity. Am J Sports Med. 1983; 11:249–252.
Article
10. Said G. Vasculitic neuropathy. Curr Opin Neurol. 1999; 12:627–629.
Article
11. Hawke SH, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG. Vasculitic neuropathy. A clinical and pathological study. Brain. 1991; 114(Pt 5):2175–2190.
12. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol. 2005; 252:633–641.
Article
13. Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993; 33:4–9.
Article
14. Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol. 1988; 23:461–465.
Article
15. Mawdsley C, Mayer RF. Nerve conduction in alcoholic polyneuropathy. Brain. 1965; 88:335–356.
Article
16. Vittadini G, Buonocore M, Colli G, Terzi M, Fonte R, Biscaldi G. Alcoholic polyneuropathy: a clinical and epidemiological study. Alcohol Alcohol. 2001; 36:393–400.
Article
17. Koike H, Sobue G. Alcoholic neuropathy. Curr Opin Neurol. 2006; 19:481–486.
Article
18. Shields RW Jr. Alcoholic polyneuropathy. Muscle Nerve. 1985; 8:183–187.
Article
19. McCombe PA, McLeod JG. The peripheral neuropathy of vitamin B12 deficiency. J Neurol Sci. 1984; 66:117–126.
Article
20. Rizzo G, Lagana AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, et al. Vitamin B12 among Vegetarians: Status, Assessment and Supplementation. Nutrients. 2016; 8.
Article
21. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurology. 2006; 5:949–960.
Article
22. Vilholm OJ, Christensen AA, Zedan AH, Itani M. Drug-induced peripheral neuropathy. Basic Clin Pharmacol Toxicol. 2014; 115:185–192.
Article
23. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008; 13:27–46.
Article
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr